Campuzano MG

Language: Spanish
References: 17
Page: 409-410
PDF size: 205.74 Kb.

Text Extraction

No abstract.

REFERENCES

1. Ogilvie C, Fitzsimons K, Fitzsimons EJ. Serum ferritin values in primary care: are high values overlooked? J Clin Pathol 2010;63:1124-1126.

2. Ho CH. The differential diagnostic values of serum transferrin receptor, serum ferritin and related parameters in the patients with various causes of anemia. Haematologica 2001;86:206-207.

3. Birgegard G, Hallgren R, Killander A, Stromberg A, Venge P, Wide L. Serum ferritin during infection. A longitudinal study. Scand J Haematol 1978;21:333-340.

4. Herbert V, Jayatilleke E, Shaw S, Rosman AS, Giardina P, Grady RW, et al. Serum ferritin iron, a new test, measures human body iron stores unconfounded by inflammation. Stem Cells 1997;15:291-296.

5. Seyhan S, Pamuk ON, Pamuk GE, Cakir N. The correlation between ferritin level and acute phase parameters in rheumatoid arthritis and systemic lupus erythematosus. Eur J Rheumatol 2014;1:92-95.

6. Thachil J. The beneficial effect of acute phase increase in serum ferritin. Eur J Intern Med 2016;35:e16-e17.

7. Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997;349:95-97.

8. Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis 2005;9:37-53.

9. Yip WW, Burt AD. Alcoholic liver disease. Semin Diagn Pathol 2006;23:149-160.

10. Wu J, Chen L, Chen Y, Yang J, Wu D. Serum ferritin concentration predicts mortality in patients with hepatitis B virus-related acute on chronic liver failure. Arch Med Res 2014;45:251-256.

11. Uchino K, Tateishi R, Fujiwara N, Minami T, Sato M, Enooku K, et al. Impact of serum ferritin level on hepatocarcinogenesis in chronic hepatitis C patients. Hepatol Res 2016;46:259-268.

12. Barton JC. Hemochromatosis and iron overload: from bench to clinic. Am J Med Sci 2013;346:403-412.

13. McLaren GD, Gordeuk VR. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Hematology Am Soc Hematol Educ Program 2009;195-206.

14. Mathurin P, Beuzin F, Louvet A, Carrie-Ganne N, Balian A, Trinchet JC, et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment Pharmacol Ther 2007;25:1047-1054.

15. Carithers RL, McClain CJ. Alcoholic liver disease. In: Sleisenger and Fordtran´s Gastrointestinal and liver disease pathophysiology diagnosis management, edited by Feldman M, Friedman LS, Brandt LJ. Philadelphia: Saunders Elsevier, 2016, p. 1409-1427.

16. Creighton Mitchell T, McClain DA. Diabetes and hemochromatosis. Curr Diab Rep 2014;14:488.

17. Campuzano-Maya G. Estudio del paciente con hiperferritinemia. Medicina & Laboratorio 2017;23:411-442.